[Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice].

Aim: To evaluate the efficiency and safety of long-term Prolia therapy in patients with postmenopausal osteoporosis (OP).

Subjects And Methods: The open prospective study enrolled 98 women (mean age, 68±9 years; mean menopause duration, 17±4 years) with postmenopausal OP, who were followed up in an outpatient setting at the National Medical Research Center for Preventive Medicine and who had been treated with denosumab 60 mg subcutaneously every 6 months for 12 months or more. The maximum follow-up period was 4 years: 48, 29, 11, and 10 patients were treated for 12, 24, 36, and 48 months, respectively.

[Associations of lipoproteins with bone mass in postmenopausal women].

Aim: To study an association between blood lipid composition and bone mass in Russian postmenopausal women.

Subjects And Methods: The cross-sectional study included 373 postmenopausal women aged 45-80 years who were examined to diagnose osteoporosis in outpatient settings. Height, body weight, and waist and hip circumferences (WC and HC) were measured before densitometry.

[Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department].

Aim: To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments.

Material And Methods: Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003.

Results: Arterial hypertension, coronary heart disease were diagnosed in 93.